Researchers in the U.S. and U.K. are testing Type 2 diabetes drug Ozempic and weight loss therapy Wegovy for their potential in diminishing dementia and addiction, CNBC reported Sept. 7. 

Pharmacists are overworked and understaffed, according to the California Board of Pharmacy, and it may be what is leading them to make up to 5 million errors each year, the Los Angeles Times reported Sept. 5.

Amid a late-summer increase in COVID-19 cases and hospitalizations, the next booster shot targeting XBB.1.5 might be available as early as Sept. 13. 

CMS bookmarked $9 billion for the 2,600 340B hospitals to repay unlawful payment cuts, and nearly half, $4.3 billion, is planned for 100 of those hospitals, according to data from the Community Oncology Alliance. 

When UPMC was short on COVID-19 monoclonal antibody Evusheld, the Pittsburgh-based system assembled a weighted lottery for equitable care, according to a study published Sept. 1 in JAMA. 

As quality issues remain as the main reason drugs fall into shortages, the FDA unveiled a plan to incentivize drugmakers to invest in quality measures, according to a white paper.

Besides AI, one emerging technology is snatching the attention of Joe Burczynski, PharmD, which performs tasks in a manner similar to completing a "Where's Waldo?" game with immediate success.

D.W. McMillan Memorial Hospital in Brewton, Ala., chose Amy Holland, PharmD, as its pharmacy director, according to an Aug. 28 news release.

An average of 80 antibiotic doses were wasted daily at Children's Healthcare of Atlanta between 2020 and 2021, which cost the system about $233,000, according to a study conducted by employees of the three-hospital system and Atlanta-based Emory University. 

Walmart allegedly urged its leaders to ask some of the company's 16,000 pharmacists to voluntarily reduce their working hours, Reuters reported Aug. 29. The company rebuffed these claims. 

Chattanooga, Tenn.-based Erlanger Health System partnered with Shields Health Solutions, a specialty pharmacy business owned by Walgreens, to build a new specialty pharmacy program. 

After a tornado damaged one of the largest sterile injectable drug manufacturing facilities in the world, Pfizer predicted the Rocky Mount, N.C., plant will be producing again in the next few months.

Four Type 2 diabetes drugs are in CMS' lineup of the 10 drugs that face price negotiations between the agency and their makers. 

Some payers aren't covering the recently approved vaccines for respiratory syncytial virus, leaving older adults to cough up $330 out of pocket, The New York Times reported Aug. 25. 

While some hospitals are paying five to 10 times more for cancer drugs during a monthslong shortage, the U.S. saw 14 new drug supply issues since early August. 

Philadelphia-based Fox Chase Cancer Center named Dapo Amosu, PharmD, as its senior pharmacy director. 

Rite Aid is preparing to file for Chapter 11 bankruptcy this fall as it faces numerous lawsuits over its alleged role in the opioid epidemic, people familiar with the matter told The Wall Street Journal. 

The Hawaii Department of Health and Honolulu-based Kapiolani Medical Center for Women and Children have agreed to partner in purchasing a year's supply of mifepristone — equivalent to 1,000 doses, according to an Aug. 24 news release. 

Matthew Jenkins, PharmD, will become Richmond, Va.-based VCU Health's first chief pharmacy officer on Sept. 17. 

CVS unveiled Cordavis, a new subsidiary focused on biosimilars in the U.S., on Aug. 23.